(Q36511584)

14 August 2017

1 reference

title

Clinical use of non-A botulinum toxins: botulinum toxin type B. (English)

1 reference

14 August 2017

D Dressler

1

1 reference

14 August 2017

R Eleopra

series ordinal

2

1 reference

14 August 2017

publication date

1 April 2006

1 reference

14 August 2017

published in

Neurotoxicity Research

1 reference

14 August 2017

volume

9

1 reference

14 August 2017

issue

2-3

1 reference

14 August 2017

page(s)

121-125

1 reference

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Treatment with botulinum toxin type B for upper-limb spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Clinical presentation and management of antibody-induced failure of botulinum toxin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

The role of botulinum toxin type B (Myobloc) in the treatment of hyperkinetic facial lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Botulinum toxin type B in piriformis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Botulinum toxin B reduces sialorrhea in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Botulinum toxin B treatment in children with spastic movement disorders: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033929

Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis

21 January 2018

1 reference

12 December 2020

Treatment of overactive bladder with botulinum toxin type B: a pilot study

1 reference

12 December 2020

Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis

1 reference

12 December 2020

Botulinum toxin type B in the treatment of anal fissures: first preliminary results

1 reference

12 December 2020

Botulinum toxin type B for treatment of spasmodic dysphonia: a case report.

1 reference

12 December 2020

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

1 reference

12 December 2020

Botulinum toxin type B for treatment of axillar hyperhidrosis

1 reference

12 December 2020

Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure

1 reference

12 December 2020

Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure

1 reference

12 December 2020

[Initial experiences with clinical use of botulinum toxin type B]

1 reference

12 December 2020

Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis

1 reference

12 December 2020

Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm

1 reference

12 December 2020

[Treatment of hip adductor spasticity with botulinum toxin type B]

1 reference

12 December 2020

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

1 reference

12 December 2020

Use of botulinum toxin type B for migraine and tension headaches

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033929

1 reference

14 August 2017

1 reference